Weiguo Su succeeding Hogg as Hutchmed CEO

Hutchmed China Ltd. (LSE:HCM; NASDAQ:HCM; HKEX:0013) has selected longtime company executive Weiguo Su to succeed CEO Christian Hogg, who is retiring. Hogg became Hutchmed’s first employee when he joined 22 years ago, and, after 27 years in China, the executive has decided to return home to Europe to focus on his family. Su, who joined Hutchmed in 2005 and has been CSO for a decade, will continue to lead R&D for the company.

Jane Huang has resigned as CMO, hematology, at BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160; Shanghai:688235). She is one of two CMOs at the company; Yong Ben is CMO, solid tumors. The company’s global head of R&D is Lai Wang. ...